Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3k5e | K5E | Kinesin-like protein KIF11 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3k5e | K5E | Kinesin-like protein KIF11 | / | 1.000 | |
| 1x88 | NAT | Kinesin-like protein KIF11 | / | 0.678 | |
| 2x7c | KZ9 | Kinesin-like protein KIF11 | / | 0.667 | |
| 2ieh | MOY | Kinesin-like protein KIF11 | / | 0.648 | |
| 2fme | 3QC | Kinesin-like protein KIF11 | / | 0.644 | |
| 2x7d | EGB | Kinesin-like protein KIF11 | / | 0.629 | |
| 2x7e | X7E | Kinesin-like protein KIF11 | / | 0.628 | |
| 3k3b | L31 | Kinesin-like protein KIF11 | / | 0.613 | |
| 1q0b | NAT | Kinesin-like protein KIF11 | / | 0.610 | |
| 2q2z | MKK | Kinesin-like protein KIF11 | / | 0.597 | |
| 4bbg | V02 | Kinesin-like protein KIF11 | / | 0.588 | |
| 2xae | 2XA | Kinesin-like protein KIF11 | / | 0.586 | |
| 3ken | ZZD | Kinesin-like protein KIF11 | / | 0.578 | |
| 2g1q | N9H | Kinesin-like protein KIF11 | / | 0.561 | |
| 2wog | ZZD | Kinesin-like protein KIF11 | / | 0.551 | |
| 2x2r | X2O | Kinesin-like protein KIF11 | / | 0.547 | |
| 4a51 | DQ8 | Kinesin-like protein KIF11 | / | 0.546 | |
| 2gm1 | 2AZ | Kinesin-like protein KIF11 | / | 0.533 | |
| 4as7 | 6LX | Kinesin-like protein KIF11 | / | 0.493 | |
| 4a5y | G7X | Kinesin-like protein KIF11 | / | 0.492 | |
| 3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.480 | |
| 3i5x | ANP | ATP-dependent RNA helicase MSS116, mitochondrial | 3.6.4.13 | 0.477 | |
| 3uk6 | ADP | RuvB-like 2 | 3.6.4.12 | 0.471 | |
| 1hfq | MOT | Dihydrofolate reductase | 1.5.1.3 | 0.462 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 3p3c | 3P3 | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.459 | |
| 1m0w | ANP | Glutathione synthetase | 6.3.2.3 | 0.458 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.456 | |
| 4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.456 | |
| 1rx4 | DDF | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
| 2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 2yj5 | ATP | Copper-transporting ATPase | / | 0.454 | |
| 4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
| 1fm6 | 9CR | Retinoic acid receptor RXR-alpha | / | 0.452 | |
| 1iep | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.452 | |
| 2e94 | 364 | Geranylgeranyl pyrophosphate synthase | / | 0.452 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 3uhm | RFN | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.451 | |
| 2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.450 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.448 | |
| 1tou | B1V | Fatty acid-binding protein, adipocyte | / | 0.448 | |
| 3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.448 | |
| 2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
| 3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4if5 | ACO | Alpha-tubulin N-acetyltransferase 1 | / | 0.447 | |
| 3nd6 | ATP | Phosphopantetheine adenylyltransferase | / | 0.446 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2ptf | FMN | Uncharacterized protein MTH_863 | / | 0.445 | |
| 3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4c2z | 646 | Glycylpeptide N-tetradecanoyltransferase 1 | / | 0.445 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.445 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.444 | |
| 4i9z | 5BA | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.444 | |
| 2d1s | SLU | Luciferin 4-monooxygenase | 1.13.12.7 | 0.443 | |
| 2igy | A2T | Plasmepsin 2 | / | 0.443 | |
| 3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.442 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.442 | |
| 3q8h | AO9 | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.442 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.442 | |
| 2a1m | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 4gv2 | 5ME | Poly [ADP-ribose] polymerase 3 | 2.4.2.30 | 0.441 | |
| 1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2our | CMP | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3wsj | MK1 | Protease | / | 0.440 |